Bonus Episode for May 8. Financial results from pharmaceutical companies <a href="https://www.wsj.com/health/pharma/eli-lilly-sales-profits-surge-on-weight-loss-drugs-5eef007e?mod=WSJ_WNPOD">Eli Lilly</a>, <a href="https://www.wsj.com/health/pharma/wegovy-maker-novo-nordisk-lifts-guidance-following-strong-launch-of-weight-loss-pill-07d495be?mod=WSJ_WNPOD">Novo Nordisk</a>, <a href="https://www.wsj.com/health/pharma/merck-sales-rise-on-continued-keytruda-growth-062c735c?mod=WSJ_WNPOD">Merck</a>, <a href="https://www.wsj.com/health/pharma/bristol-myers-squibb-logs-higher-sales-profit-e01468fa?mod=WSJ_WNPOD">Bristol Myers Squibb</a> and <a href="https://www.wsj.com/business/retail/abbvie-raises-fy-guidance-on-immunology-neuroscience-growth-1daafa96?mod=WSJ_WNPOD">AbbVie</a> show strong demand continuing for weight-loss drugs and autoimmune treatments. Wall Street Journal pharma reporter <a href="https://www.wsj.com/news/author/peter-loftus?mod=WSJ_WNPOD">Peter Loftus</a> discusses which drugmakers have the upper hand in the race to dominate those markets. 

WSJ Heard on the Street columnist <a href="https://www.wsj.com/news/author/david-wainer?mod=WSJ_WNPOD">David Wainer</a> hosts this special bonus episode of What's News in Earnings, where we dig into companies’ earnings reports and analyst calls to find out what’s going on under the hood of the American economy.

Sign up for the WSJ's free <a href="https://www.wsj.com/newsletters/markets-am?mod=WSJ_WNPOD">Markets A.M. newsletter</a>.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

What’s News in Earnings: How Big Pharma Is Expanding the GLP-1 Market

WSJ What’s News

AI Chapters

AI Insights

Reviews